Acquired Rifampicin Resistance in Thrice-Weekly Antituberculosis Therapy: Impact of HIV and Antiretroviral Therapy
- Author
- NARENDRAN, Gopalan1 ; PRADEEP ARAVINDAN MENON1 ; KUMAR, Satagopan2 ; SRIDHAR, Rathinam3 ; SWAMINATHAN, Soumya1 ; VENKATESAN, Perumal1 ; VIJAY, Krishnamoorthy1 ; PADMAPRIYADARSINI, Chandrasekaran1 ; SANTHANAKRISHNAN RAMESH KUMAR1 ; KANNABIRAN PERUMAL BHAVANI1 ; SEKAR, Lakshmanan1 ; SIVARAMAKRISHNAN NARAYAN GOMATHI1 ; CHANDRASEKHAR, Chockalingam2
[1] National Institute for Research in Tuberculosis (formerly Tuberculosis Research Centre), Chetpet, India
[2] Government Hospital of Thoracic Medicine, Tambaram Sanatorium, India
[3] Government Stanley Hospital, Tondiarpet, Chennai, India - Source
Clinical infectious diseases. 2014, Vol 59, Num 12, pp 1798-1804, 7 p ; ref : 31 ref
- Publisher
- Oxford University Press, Oxford
- Publication country
- United Kingdom
- Document type
- Article
- Language
- English
- Keyword (fr)
- Antibactérien Antibiotique Antirétroviral Antituberculeux Antiviral Chimiothérapie Rifampicine Résistance SIDA Virus immunodéficience humaine Dose hebdomadaire Immunodéficit Immunopathologie Infection Inhibiteur synthèse protéique Lentivirus Retroviridae Traitement Virose Virus
- Keyword (en)
- Antibacterial agent Antibiotic Antiretroviral agent Antituberculous agent Antiviral Chemotherapy Rifampicin Resistance AIDS Human immunodeficiency virus Immune deficiency Immunopathology Infection Protein synthesis inhibitor Lentivirus Retroviridae Treatment Viral disease Virus
- Keyword (es)
- Antibacteriano Antibiótico Antiretroviral Antituberculoso Antiviral Quimioterapia Rifampicina Resistencia SIDA Human immunodeficiency virus Inmunodeficiencia Inmunopatología Infección Inhibidor síntesis proteica Lentivirus Retroviridae Tratamiento Virosis Virus
- Classification
- Pascal
- 002 Biological and medical sciences / 002B Medical sciences / 002B02 Pharmacology. Drug treatments / 002B02S Antibiotics. Antiinfectious agents. Antiparasitic agents / 002B02S02 Antibacterial agents
- Pascal
- 002 Biological and medical sciences / 002B Medical sciences / 002B02 Pharmacology. Drug treatments / 002B02S Antibiotics. Antiinfectious agents. Antiparasitic agents / 002B02S05 Antiviral agents
- Pascal
- 002 Biological and medical sciences / 002B Medical sciences / 002B05 Infectious diseases / 002B05C Viral diseases / 002B05C02 Human viral diseases / 002B05C02D Viral diseases of the lymphoid tissue and the blood. Aids
- Discipline
- Infectious pathology Pharmacological treatments
- Origin
- Inist-CNRS
- Database
- PASCAL
- INIST identifier
- 29053714
Sauf mention contraire ci-dessus, le contenu de cette notice bibliographique peut être utilisé dans le cadre d’une licence CC BY 4.0 Inist-CNRS / Unless otherwise stated above, the content of this bibliographic record may be used under a CC BY 4.0 licence by Inist-CNRS / A menos que se haya señalado antes, el contenido de este registro bibliográfico puede ser utilizado al amparo de una licencia CC BY 4.0 Inist-CNRS
Access to the document
Install on your browser
DOI
10.1093/cid/ciu674 
https://dx.doi.org/10.1093/cid/ciu674
"O:13:\"PanistOpenUrl\":36:{s:10:\"\u0000*\u0000openUrl\";N;s:6:\"\u0000*\u0000idc\";N;s:6:\"\u0000*\u0000fmt\";s:7:\"journal\";s:6:\"\u0000*\u0000doi\";s:18:\"10.1093\/cid\/ciu674\";s:6:\"\u0000*\u0000pii\";s:0:\"\";s:7:\"\u0000*\u0000pmid\";s:0:\"\";s:9:\"\u0000*\u0000atitle\";s:114:\"Acquired Rifampicin Resistance in Thrice-Weekly Antituberculosis Therapy: Impact of HIV and Antiretroviral Therapy\";s:9:\"\u0000*\u0000jtitle\";s:28:\"Clinical infectious diseases\";s:9:\"\u0000*\u0000stitle\";s:17:\"Clin. infect. dis\";s:7:\"\u0000*\u0000date\";s:4:\"2014\";s:9:\"\u0000*\u0000volume\";s:2:\"59\";s:8:\"\u0000*\u0000issue\";s:2:\"12\";s:8:\"\u0000*\u0000spage\";s:4:\"1798\";s:8:\"\u0000*\u0000epage\";s:4:\"1804\";s:8:\"\u0000*\u0000pages\";s:0:\"\";s:7:\"\u0000*\u0000issn\";s:9:\"1058-4838\";s:8:\"\u0000*\u0000eissn\";s:0:\"\";s:9:\"\u0000*\u0000aulast\";s:9:\"NARENDRAN\";s:10:\"\u0000*\u0000aufirst\";s:7:\"Gopalan\";s:9:\"\u0000*\u0000auinit\";s:0:\"\";s:10:\"\u0000*\u0000auinitm\";s:0:\"\";s:5:\"\u0000*\u0000au\";a:12:{i:0;s:23:\"PRADEEP ARAVINDAN MENON\";i:1;s:16:\"KUMAR, Satagopan\";i:2;s:17:\"SRIDHAR, Rathinam\";i:3;s:19:\"SWAMINATHAN, Soumya\";i:4;s:19:\"VENKATESAN, Perumal\";i:5;s:21:\"VIJAY, Krishnamoorthy\";i:6;s:33:\"PADMAPRIYADARSINI, Chandrasekaran\";i:7;s:29:\"SANTHANAKRISHNAN RAMESH KUMAR\";i:8;s:26:\"KANNABIRAN PERUMAL BHAVANI\";i:9;s:17:\"SEKAR, Lakshmanan\";i:10;s:32:\"SIVARAMAKRISHNAN NARAYAN GOMATHI\";i:11;s:27:\"CHANDRASEKHAR, Chockalingam\";}s:9:\"\u0000*\u0000aucorp\";s:0:\"\";s:7:\"\u0000*\u0000isbn\";s:0:\"\";s:8:\"\u0000*\u0000coden\";s:6:\"CIDIEL\";s:8:\"\u0000*\u0000genre\";s:7:\"article\";s:7:\"\u0000*\u0000part\";s:0:\"\";s:9:\"\u0000*\u0000btitle\";s:0:\"\";s:8:\"\u0000*\u0000title\";s:114:\"Acquired Rifampicin Resistance in Thrice-Weekly Antituberculosis Therapy: Impact of HIV and Antiretroviral Therapy\";s:8:\"\u0000*\u0000place\";s:6:\"Oxford\";s:6:\"\u0000*\u0000pub\";s:23:\"Oxford University Press\";s:10:\"\u0000*\u0000edition\";s:0:\"\";s:9:\"\u0000*\u0000tpages\";s:1:\"7\";s:9:\"\u0000*\u0000series\";s:0:\"\";s:8:\"\u0000*\u0000proxy\";s:30:\"http:\/\/proxyout.inist.fr:8080\/\";s:12:\"\u0000*\u0000integrite\";b:1;}"
Panist access
"O:12:\"IstexOpenUrl\":35:{s:10:\"\u0000*\u0000openUrl\";N;s:6:\"\u0000*\u0000fmt\";s:7:\"journal\";s:6:\"\u0000*\u0000doi\";s:18:\"10.1093\/cid\/ciu674\";s:6:\"\u0000*\u0000pii\";s:0:\"\";s:7:\"\u0000*\u0000pmid\";s:0:\"\";s:9:\"\u0000*\u0000atitle\";s:114:\"Acquired Rifampicin Resistance in Thrice-Weekly Antituberculosis Therapy: Impact of HIV and Antiretroviral Therapy\";s:9:\"\u0000*\u0000jtitle\";s:28:\"Clinical infectious diseases\";s:9:\"\u0000*\u0000stitle\";s:17:\"Clin. infect. dis\";s:7:\"\u0000*\u0000date\";s:4:\"2014\";s:9:\"\u0000*\u0000volume\";s:2:\"59\";s:8:\"\u0000*\u0000issue\";s:2:\"12\";s:8:\"\u0000*\u0000spage\";s:4:\"1798\";s:8:\"\u0000*\u0000epage\";s:4:\"1804\";s:8:\"\u0000*\u0000pages\";s:0:\"\";s:7:\"\u0000*\u0000issn\";s:9:\"1058-4838\";s:8:\"\u0000*\u0000eissn\";s:0:\"\";s:9:\"\u0000*\u0000aulast\";s:9:\"NARENDRAN\";s:10:\"\u0000*\u0000aufirst\";s:7:\"Gopalan\";s:9:\"\u0000*\u0000auinit\";s:0:\"\";s:10:\"\u0000*\u0000auinitm\";s:0:\"\";s:5:\"\u0000*\u0000au\";a:12:{i:0;s:23:\"PRADEEP ARAVINDAN MENON\";i:1;s:16:\"KUMAR, Satagopan\";i:2;s:17:\"SRIDHAR, Rathinam\";i:3;s:19:\"SWAMINATHAN, Soumya\";i:4;s:19:\"VENKATESAN, Perumal\";i:5;s:21:\"VIJAY, Krishnamoorthy\";i:6;s:33:\"PADMAPRIYADARSINI, Chandrasekaran\";i:7;s:29:\"SANTHANAKRISHNAN RAMESH KUMAR\";i:8;s:26:\"KANNABIRAN PERUMAL BHAVANI\";i:9;s:17:\"SEKAR, Lakshmanan\";i:10;s:32:\"SIVARAMAKRISHNAN NARAYAN GOMATHI\";i:11;s:27:\"CHANDRASEKHAR, Chockalingam\";}s:9:\"\u0000*\u0000aucorp\";s:0:\"\";s:7:\"\u0000*\u0000isbn\";s:0:\"\";s:8:\"\u0000*\u0000coden\";s:6:\"CIDIEL\";s:8:\"\u0000*\u0000genre\";s:7:\"article\";s:7:\"\u0000*\u0000part\";s:0:\"\";s:9:\"\u0000*\u0000btitle\";s:0:\"\";s:8:\"\u0000*\u0000title\";s:114:\"Acquired Rifampicin Resistance in Thrice-Weekly Antituberculosis Therapy: Impact of HIV and Antiretroviral Therapy\";s:8:\"\u0000*\u0000place\";s:6:\"Oxford\";s:6:\"\u0000*\u0000pub\";s:23:\"Oxford University Press\";s:10:\"\u0000*\u0000edition\";s:0:\"\";s:9:\"\u0000*\u0000tpages\";s:1:\"7\";s:9:\"\u0000*\u0000series\";s:0:\"\";s:8:\"\u0000*\u0000proxy\";s:30:\"http:\/\/proxyout.inist.fr:8080\/\";s:12:\"\u0000*\u0000integrite\";b:1;}"
Istex access
"O:16:\"UnpaywallOpenUrl\":35:{s:8:\"\u0000*\u0000email\";s:27:\"assistance-portail@inist.fr\";s:6:\"\u0000*\u0000fmt\";N;s:6:\"\u0000*\u0000doi\";s:18:\"10.1093\/cid\/ciu674\";s:6:\"\u0000*\u0000pii\";N;s:7:\"\u0000*\u0000pmid\";N;s:9:\"\u0000*\u0000atitle\";N;s:9:\"\u0000*\u0000jtitle\";N;s:9:\"\u0000*\u0000stitle\";N;s:7:\"\u0000*\u0000date\";N;s:9:\"\u0000*\u0000volume\";N;s:8:\"\u0000*\u0000issue\";N;s:8:\"\u0000*\u0000spage\";N;s:8:\"\u0000*\u0000epage\";N;s:8:\"\u0000*\u0000pages\";N;s:7:\"\u0000*\u0000issn\";N;s:8:\"\u0000*\u0000eissn\";N;s:9:\"\u0000*\u0000aulast\";N;s:10:\"\u0000*\u0000aufirst\";N;s:9:\"\u0000*\u0000auinit\";N;s:10:\"\u0000*\u0000auinitm\";N;s:5:\"\u0000*\u0000au\";N;s:9:\"\u0000*\u0000aucorp\";N;s:7:\"\u0000*\u0000isbn\";N;s:8:\"\u0000*\u0000coden\";N;s:8:\"\u0000*\u0000genre\";N;s:7:\"\u0000*\u0000part\";N;s:9:\"\u0000*\u0000btitle\";N;s:8:\"\u0000*\u0000title\";N;s:8:\"\u0000*\u0000place\";N;s:6:\"\u0000*\u0000pub\";N;s:10:\"\u0000*\u0000edition\";N;s:9:\"\u0000*\u0000tpages\";N;s:9:\"\u0000*\u0000series\";N;s:8:\"\u0000*\u0000proxy\";s:30:\"http:\/\/proxyout.inist.fr:8080\/\";s:12:\"\u0000*\u0000integrite\";N;}"
Unpaywall access
"O:16:\"EuropePMCOpenUrl\":35:{s:10:\"\u0000*\u0000openUrl\";N;s:6:\"\u0000*\u0000fmt\";s:7:\"journal\";s:6:\"\u0000*\u0000doi\";s:18:\"10.1093\/cid\/ciu674\";s:6:\"\u0000*\u0000pii\";s:0:\"\";s:7:\"\u0000*\u0000pmid\";s:0:\"\";s:9:\"\u0000*\u0000atitle\";s:114:\"Acquired Rifampicin Resistance in Thrice-Weekly Antituberculosis Therapy: Impact of HIV and Antiretroviral Therapy\";s:9:\"\u0000*\u0000jtitle\";s:28:\"Clinical infectious diseases\";s:9:\"\u0000*\u0000stitle\";s:17:\"Clin. infect. dis\";s:7:\"\u0000*\u0000date\";s:4:\"2014\";s:9:\"\u0000*\u0000volume\";s:2:\"59\";s:8:\"\u0000*\u0000issue\";s:2:\"12\";s:8:\"\u0000*\u0000spage\";s:4:\"1798\";s:8:\"\u0000*\u0000epage\";s:4:\"1804\";s:8:\"\u0000*\u0000pages\";s:0:\"\";s:7:\"\u0000*\u0000issn\";s:9:\"1058-4838\";s:8:\"\u0000*\u0000eissn\";s:0:\"\";s:9:\"\u0000*\u0000aulast\";s:9:\"NARENDRAN\";s:10:\"\u0000*\u0000aufirst\";s:7:\"Gopalan\";s:9:\"\u0000*\u0000auinit\";s:0:\"\";s:10:\"\u0000*\u0000auinitm\";s:0:\"\";s:5:\"\u0000*\u0000au\";a:12:{i:0;s:23:\"PRADEEP ARAVINDAN MENON\";i:1;s:16:\"KUMAR, Satagopan\";i:2;s:17:\"SRIDHAR, Rathinam\";i:3;s:19:\"SWAMINATHAN, Soumya\";i:4;s:19:\"VENKATESAN, Perumal\";i:5;s:21:\"VIJAY, Krishnamoorthy\";i:6;s:33:\"PADMAPRIYADARSINI, Chandrasekaran\";i:7;s:29:\"SANTHANAKRISHNAN RAMESH KUMAR\";i:8;s:26:\"KANNABIRAN PERUMAL BHAVANI\";i:9;s:17:\"SEKAR, Lakshmanan\";i:10;s:32:\"SIVARAMAKRISHNAN NARAYAN GOMATHI\";i:11;s:27:\"CHANDRASEKHAR, Chockalingam\";}s:9:\"\u0000*\u0000aucorp\";s:0:\"\";s:7:\"\u0000*\u0000isbn\";s:0:\"\";s:8:\"\u0000*\u0000coden\";s:6:\"CIDIEL\";s:8:\"\u0000*\u0000genre\";s:7:\"article\";s:7:\"\u0000*\u0000part\";s:0:\"\";s:9:\"\u0000*\u0000btitle\";s:0:\"\";s:8:\"\u0000*\u0000title\";s:114:\"Acquired Rifampicin Resistance in Thrice-Weekly Antituberculosis Therapy: Impact of HIV and Antiretroviral Therapy\";s:8:\"\u0000*\u0000place\";s:6:\"Oxford\";s:6:\"\u0000*\u0000pub\";s:23:\"Oxford University Press\";s:10:\"\u0000*\u0000edition\";s:0:\"\";s:9:\"\u0000*\u0000tpages\";s:1:\"7\";s:9:\"\u0000*\u0000series\";s:0:\"\";s:8:\"\u0000*\u0000proxy\";s:30:\"http:\/\/proxyout.inist.fr:8080\/\";s:12:\"\u0000*\u0000integrite\";b:1;}"
Europe PubMed Central access
"O:11:\"BaseOpenUrl\":35:{s:10:\"\u0000*\u0000openUrl\";N;s:6:\"\u0000*\u0000fmt\";s:7:\"journal\";s:6:\"\u0000*\u0000doi\";s:18:\"10.1093\/cid\/ciu674\";s:6:\"\u0000*\u0000pii\";s:0:\"\";s:7:\"\u0000*\u0000pmid\";s:0:\"\";s:9:\"\u0000*\u0000atitle\";s:114:\"Acquired Rifampicin Resistance in Thrice-Weekly Antituberculosis Therapy: Impact of HIV and Antiretroviral Therapy\";s:9:\"\u0000*\u0000jtitle\";s:28:\"Clinical infectious diseases\";s:9:\"\u0000*\u0000stitle\";s:17:\"Clin. infect. dis\";s:7:\"\u0000*\u0000date\";s:4:\"2014\";s:9:\"\u0000*\u0000volume\";s:2:\"59\";s:8:\"\u0000*\u0000issue\";s:2:\"12\";s:8:\"\u0000*\u0000spage\";s:4:\"1798\";s:8:\"\u0000*\u0000epage\";s:4:\"1804\";s:8:\"\u0000*\u0000pages\";s:0:\"\";s:7:\"\u0000*\u0000issn\";s:9:\"1058-4838\";s:8:\"\u0000*\u0000eissn\";s:0:\"\";s:9:\"\u0000*\u0000aulast\";s:9:\"NARENDRAN\";s:10:\"\u0000*\u0000aufirst\";s:7:\"Gopalan\";s:9:\"\u0000*\u0000auinit\";s:0:\"\";s:10:\"\u0000*\u0000auinitm\";s:0:\"\";s:5:\"\u0000*\u0000au\";a:12:{i:0;s:23:\"PRADEEP ARAVINDAN MENON\";i:1;s:16:\"KUMAR, Satagopan\";i:2;s:17:\"SRIDHAR, Rathinam\";i:3;s:19:\"SWAMINATHAN, Soumya\";i:4;s:19:\"VENKATESAN, Perumal\";i:5;s:21:\"VIJAY, Krishnamoorthy\";i:6;s:33:\"PADMAPRIYADARSINI, Chandrasekaran\";i:7;s:29:\"SANTHANAKRISHNAN RAMESH KUMAR\";i:8;s:26:\"KANNABIRAN PERUMAL BHAVANI\";i:9;s:17:\"SEKAR, Lakshmanan\";i:10;s:32:\"SIVARAMAKRISHNAN NARAYAN GOMATHI\";i:11;s:27:\"CHANDRASEKHAR, Chockalingam\";}s:9:\"\u0000*\u0000aucorp\";s:0:\"\";s:7:\"\u0000*\u0000isbn\";s:0:\"\";s:8:\"\u0000*\u0000coden\";s:6:\"CIDIEL\";s:8:\"\u0000*\u0000genre\";s:7:\"article\";s:7:\"\u0000*\u0000part\";s:0:\"\";s:9:\"\u0000*\u0000btitle\";s:0:\"\";s:8:\"\u0000*\u0000title\";s:114:\"Acquired Rifampicin Resistance in Thrice-Weekly Antituberculosis Therapy: Impact of HIV and Antiretroviral Therapy\";s:8:\"\u0000*\u0000place\";s:6:\"Oxford\";s:6:\"\u0000*\u0000pub\";s:23:\"Oxford University Press\";s:10:\"\u0000*\u0000edition\";s:0:\"\";s:9:\"\u0000*\u0000tpages\";s:1:\"7\";s:9:\"\u0000*\u0000series\";s:0:\"\";s:8:\"\u0000*\u0000proxy\";s:30:\"http:\/\/proxyout.inist.fr:8080\/\";s:12:\"\u0000*\u0000integrite\";b:1;}"
Base Search access
"O:12:\"ArXivOpenUrl\":35:{s:10:\"\u0000*\u0000openUrl\";N;s:6:\"\u0000*\u0000fmt\";s:7:\"journal\";s:6:\"\u0000*\u0000doi\";s:18:\"10.1093\/cid\/ciu674\";s:6:\"\u0000*\u0000pii\";s:0:\"\";s:7:\"\u0000*\u0000pmid\";s:0:\"\";s:9:\"\u0000*\u0000atitle\";s:114:\"Acquired Rifampicin Resistance in Thrice-Weekly Antituberculosis Therapy: Impact of HIV and Antiretroviral Therapy\";s:9:\"\u0000*\u0000jtitle\";s:28:\"Clinical infectious diseases\";s:9:\"\u0000*\u0000stitle\";s:17:\"Clin. infect. dis\";s:7:\"\u0000*\u0000date\";s:4:\"2014\";s:9:\"\u0000*\u0000volume\";s:2:\"59\";s:8:\"\u0000*\u0000issue\";s:2:\"12\";s:8:\"\u0000*\u0000spage\";s:4:\"1798\";s:8:\"\u0000*\u0000epage\";s:4:\"1804\";s:8:\"\u0000*\u0000pages\";s:0:\"\";s:7:\"\u0000*\u0000issn\";s:9:\"1058-4838\";s:8:\"\u0000*\u0000eissn\";s:0:\"\";s:9:\"\u0000*\u0000aulast\";s:9:\"NARENDRAN\";s:10:\"\u0000*\u0000aufirst\";s:7:\"Gopalan\";s:9:\"\u0000*\u0000auinit\";s:0:\"\";s:10:\"\u0000*\u0000auinitm\";s:0:\"\";s:5:\"\u0000*\u0000au\";a:12:{i:0;s:23:\"PRADEEP ARAVINDAN MENON\";i:1;s:16:\"KUMAR, Satagopan\";i:2;s:17:\"SRIDHAR, Rathinam\";i:3;s:19:\"SWAMINATHAN, Soumya\";i:4;s:19:\"VENKATESAN, Perumal\";i:5;s:21:\"VIJAY, Krishnamoorthy\";i:6;s:33:\"PADMAPRIYADARSINI, Chandrasekaran\";i:7;s:29:\"SANTHANAKRISHNAN RAMESH KUMAR\";i:8;s:26:\"KANNABIRAN PERUMAL BHAVANI\";i:9;s:17:\"SEKAR, Lakshmanan\";i:10;s:32:\"SIVARAMAKRISHNAN NARAYAN GOMATHI\";i:11;s:27:\"CHANDRASEKHAR, Chockalingam\";}s:9:\"\u0000*\u0000aucorp\";s:0:\"\";s:7:\"\u0000*\u0000isbn\";s:0:\"\";s:8:\"\u0000*\u0000coden\";s:6:\"CIDIEL\";s:8:\"\u0000*\u0000genre\";s:7:\"article\";s:7:\"\u0000*\u0000part\";s:0:\"\";s:9:\"\u0000*\u0000btitle\";s:0:\"\";s:8:\"\u0000*\u0000title\";s:114:\"Acquired Rifampicin Resistance in Thrice-Weekly Antituberculosis Therapy: Impact of HIV and Antiretroviral Therapy\";s:8:\"\u0000*\u0000place\";s:6:\"Oxford\";s:6:\"\u0000*\u0000pub\";s:23:\"Oxford University Press\";s:10:\"\u0000*\u0000edition\";s:0:\"\";s:9:\"\u0000*\u0000tpages\";s:1:\"7\";s:9:\"\u0000*\u0000series\";s:0:\"\";s:8:\"\u0000*\u0000proxy\";s:30:\"http:\/\/proxyout.inist.fr:8080\/\";s:12:\"\u0000*\u0000integrite\";b:1;}"
arXiv access
